M. Bagot

19.2k total citations · 2 hit papers
365 papers, 8.2k citations indexed

About

M. Bagot is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, M. Bagot has authored 365 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Dermatology, 115 papers in Epidemiology and 115 papers in Immunology. Recurrent topics in M. Bagot's work include Cutaneous lymphoproliferative disorders research (178 papers), Lymphoma Diagnosis and Treatment (87 papers) and Fungal Infections and Studies (55 papers). M. Bagot is often cited by papers focused on Cutaneous lymphoproliferative disorders research (178 papers), Lymphoma Diagnosis and Treatment (87 papers) and Fungal Infections and Studies (55 papers). M. Bagot collaborates with scholars based in France, United States and Germany. M. Bagot's co-authors include Armand Bensussan, Hélène Bocquet, Jean Claude Roujeau, Laurence Boumsell, Jean‐Claude Roujeau, Nicolás Ortonne, P. Wolkenstein, Janine Wechsler, Célèste Lebbé and Maxime Battistella and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

M. Bagot

337 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)

1996 678 citations M. Bagot et al. profile →
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder

2016 281 citations M. Bagot et al. Journal of Investigative Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Bagot France	44	4.0k	2.7k	2.5k	2.2k	1.8k	365	8.2k
Nikhil Yawalkar Switzerland	43	2.8k 0.7×	956 0.3×	2.0k 0.8×	879 0.4×	1.5k 0.8×	158	5.5k
Martine Bagot France	38	2.4k 0.6×	1.7k 0.6×	1.8k 0.7×	1.4k 0.7×	323 0.2×	183	4.9k
M. D’Incan France	34	1.5k 0.4×	1.6k 0.6×	820 0.3×	897 0.4×	358 0.2×	144	4.1k
Emmilia Hodak Israel	40	2.7k 0.7×	1.7k 0.6×	1.0k 0.4×	1.6k 0.7×	123 0.1×	219	4.9k
Ralf J. Ludwig Germany	45	975 0.2×	3.1k 1.1×	1.7k 0.7×	472 0.2×	254 0.1×	309	7.3k
Marzia Caproni Italy	35	1.4k 0.3×	1.6k 0.6×	1.5k 0.6×	801 0.4×	296 0.2×	179	4.5k
Robert Knobler Austria	44	4.3k 1.1×	2.4k 0.9×	2.6k 1.1×	2.1k 1.0×	138 0.1×	161	7.9k
Michael Sticherling Germany	43	1.0k 0.3×	1.4k 0.5×	2.3k 0.9×	445 0.2×	148 0.1×	214	5.9k
Maria Sole Chimenti Italy	37	1.5k 0.4×	1.1k 0.4×	2.2k 0.9×	778 0.4×	128 0.1×	227	5.1k
Henry H. Roenigk United States	41	2.5k 0.6×	1.4k 0.5×	1.4k 0.6×	1.2k 0.5×	152 0.1×	134	4.8k

Countries citing papers authored by M. Bagot

Since Specialization

Citations

This map shows the geographic impact of M. Bagot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bagot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bagot more than expected).

Fields of papers citing papers by M. Bagot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bagot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bagot. The network helps show where M. Bagot may publish in the future.

Co-authorship network of co-authors of M. Bagot

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bagot. A scholar is included among the top collaborators of M. Bagot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bagot. M. Bagot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foss, Francine M., Youn H. Kim, Julia Scarisbrick, et al.. (2025). Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab. Journal of Dermatological Treatment. 36(1). 2438794–2438794. 2 indexed citations

Peltier, S., Luca Nicosia, Kévin Serror, et al.. (2024). In vitro effects of wound‐dressings on key wound healing properties of dermal fibroblasts. Experimental Dermatology. 33(5). e15098–e15098. 5 indexed citations

Campbell, Belinda A., Gábor Dobos, H. Miles Prince, et al.. (2023). International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies. Blood Advances. 7(21). 6639–6647. 19 indexed citations

Battistella, Maxime, Lin‐Pierre Zhao, Gábor Dobos, et al.. (2023). CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas. Journal of Investigative Dermatology. 143(7). 1329–1332.e3. 6 indexed citations

Kim, Y. H., M. Bagot, Pablo L. Ortiz‐Romero, et al.. (2023). LACUTAMAB IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES (MF): EFFICACY RESULTS ACCORDING TO UPDATED LYMPH NODE (LN) CLASSIFICATION IN THE TELLOMAK STUDY. Hematological Oncology. 41(S2). 196–197. 2 indexed citations

Ram‐Wolff, C., et al.. (2022). Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model. Cells. 11(19). 2933–2933. 7 indexed citations

Dobos, Gábor, Laurence Michel, Caroline Ram‐Wolff, et al.. (2022). Recent advances on cutaneous lymphoma epidemiology. La Presse Médicale. 51(1). 104108–104108. 7 indexed citations

Papadavid, Evangelia, Vasiliki Pappa, Vasiliki Nikolaou, et al.. (2021). Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*. British Journal of Dermatology. 185(5). 1035–1044. 16 indexed citations

Masson, Adèle de, Constance de Margerie‐Mellon, É. de Kerviler, et al.. (2021). Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome*. British Journal of Dermatology. 185(2). 419–427. 6 indexed citations

10.

Scarisbrick, Julia, M. Bagot, & Pablo L. Ortiz‐Romero. (2020). The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma. British Journal of Haematology. 192(4). 683–696. 22 indexed citations

11.

Papadavid, Evangelia, Julia Scarisbrick, Pablo L. Ortiz‐Romero, et al.. (2020). Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelines. Journal of the European Academy of Dermatology and Venereology. 34(8). 1633–1636. 10 indexed citations

12.

Dobos, Gábor, Anne Pohrt, Caroline Ram‐Wolff, et al.. (2020). Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients. Cancers. 12(10). 2921–2921. 75 indexed citations

13.

Porcu, Pierluigi, Stacie Hudgens, Sarah McCue Horwitz, et al.. (2020). Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(2). 97–105. 20 indexed citations

14.

Bessis, D., M. Jachiet, Dan Lipsker, et al.. (2018). Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study. Journal of the American Academy of Dermatology. 79(1). 162–165. 10 indexed citations

15.

Quaglino, Pietro, Milena Maule, H. Miles Prince, et al.. (2017). Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (vol 28, pg 2517, 2017). Annals of Oncology. 30(3). 494–494. 1 indexed citations

16.

Bohelay, G., Maxime Battistella, Cécile Pagès, et al.. (2015). Ultrasound-guided core needle biopsy of superficial lymph nodes. Melanoma Research. 25(6). 519–527. 11 indexed citations

17.

Ram‐Wolff, C., et al.. (2013). Adénite sébacée neutrophilique chez une femme. Annales de Dermatologie et de Vénéréologie. 140(11). 708–712. 1 indexed citations

18.

Dummer, Reinhard, Pietro Quaglino, Jürgen C. Becker, et al.. (2012). Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. Journal of Clinical Oncology. 30(33). 4091–4097. 70 indexed citations

19.

Bagot, M. & Armand Bensussan. (2006). Les lymphomes T épidermotropes comme modèles de progression tumorale. médecine/sciences. 22(2). 192–196. 2 indexed citations

20.

Bagot, M.. (2005). Physiopathologie, classification et traitement des lymphomes cutanés. Hématologie. 11(5). 335–343.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact